유방암 진단 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 유형별, 제품별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

The Global Breast Cancer Diagnostics Market, valued at USD 62.98 Billion in 2024, is projected to experience a CAGR of 11.21% to reach USD 119.14 Billion by 2030. The Global Breast Cancer Diagnostics Market encompasses an array of specialized tests, imaging modalities, and biopsy procedures engineered to detect, characterize, and monitor breast cancer. Market growth is primarily driven by the escalating global incidence of breast cancer, augmented public health awareness campaigns, and governmental initiatives promoting early detection and screening programs.

Key Market Drivers

The increasing global incidence of breast cancer serves as a fundamental driver for the breast cancer diagnostics market. A rising number of new cases necessitates expanded screening and diagnostic capabilities worldwide to facilitate early detection and improve patient outcomes. This persistent disease burden creates consistent demand for diverse diagnostic solutions, from initial screening to definitive diagnosis and staging. For example, according to the American Cancer Society's Breast Cancer Facts & Figures 2024, an estimated 310,720 new cases of invasive breast cancer were expected to be diagnosed in the United States in 2024, underpinning the critical need for effective diagnostic tools. This widespread health challenge reinforces the market's expansion, with breast cancer being the most common cancer in women in 157 countries out of 185 in 2022, as reported by the World Health Organization in February 2024.

Key Market Challenges

The substantial cost associated with advanced diagnostic technologies represents a significant challenging factor impeding the growth of the Global Breast Cancer Diagnostics Market. These high expenses restrict accessibility to crucial screening and diagnostic procedures, particularly within developing economies where healthcare budgets are often constrained. This financial barrier limits the widespread adoption of comprehensive diagnostic screening protocols across various regions.

Key Market Trends

The growing adoption of liquid biopsy for early detection and monitoring represents a pivotal shift in breast cancer diagnostics. This non-invasive technique, which analyzes circulating tumor DNA or cells from a blood sample, offers a less burdensome alternative to traditional tissue biopsies, facilitating earlier detection and ongoing disease surveillance. Its utility is becoming increasingly recognized as research progresses, with clinical applications expanding beyond advanced disease. According to the American Society of Clinical Oncology, in January 2024, five liquid biopsy companion diagnostic assays were approved by the U. S. Food and Drug Administration for their clinical application in the diagnosis of cancer.

Key Market Players

• Baxter Pharmaceuticals India Private Limited.
• Bristol-Myers Squibb India Private Limited.
• Cipla Ltd.
• Roche Products (India) Private Limited.
• Glenmark Pharmaceuticals Ltd.
• Lupin Ltd
• Abbott India Laboratories Limited
• BIO-RAD LABORATORIES (INDIA) PRIVATE LIMITED.
• Siemens Healthcare Private Limited.
• Thermo Fisher Scientific India Private Limited.

Report Scope:

In this report, the Global Breast Cancer Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Breast Cancer Diagnostics Market, By Type:

• Imaging
• Biopsy
• Genomic Tests
• Blood Tests
• Others

Breast Cancer Diagnostics Market, By Product:

• Platform-based Products
• Instrument-based Products

Breast Cancer Diagnostics Market, By Application:

• Screening
• Diagnostic and Predictive
• Prognostic
• Research
• Others

Breast Cancer Diagnostics Market, By End-use:

• Hospitals & Clinics
• Diagnostic Centers and Medical Laboratories
• Others

Breast Cancer Diagnostics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Breast Cancer Diagnostics Market.

Available Customizations:

Global Breast Cancer Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Breast Cancer Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Others)
  • 5.2.2. By Product (Platform-based Products, Instrument-based Products)
  • 5.2.3. By Application (Screening, Diagnostic and Predictive, Prognostic, Research, Others)
  • 5.2.4. By End-use (Hospitals & Clinics, Diagnostic Centers and Medical Laboratories, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Breast Cancer Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Product
  • 6.2.3. By Application
  • 6.2.4. By End-use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Breast Cancer Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End-use
  • 6.3.2. Canada Breast Cancer Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End-use
  • 6.3.3. Mexico Breast Cancer Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End-use

7. Europe Breast Cancer Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Product
  • 7.2.3. By Application
  • 7.2.4. By End-use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Breast Cancer Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End-use
  • 7.3.2. France Breast Cancer Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End-use
  • 7.3.3. United Kingdom Breast Cancer Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End-use
  • 7.3.4. Italy Breast Cancer Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End-use
  • 7.3.5. Spain Breast Cancer Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End-use

8. Asia Pacific Breast Cancer Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Product
  • 8.2.3. By Application
  • 8.2.4. By End-use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Breast Cancer Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End-use
  • 8.3.2. India Breast Cancer Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End-use
  • 8.3.3. Japan Breast Cancer Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End-use
  • 8.3.4. South Korea Breast Cancer Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End-use
  • 8.3.5. Australia Breast Cancer Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End-use

9. Middle East & Africa Breast Cancer Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Product
  • 9.2.3. By Application
  • 9.2.4. By End-use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Breast Cancer Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End-use
  • 9.3.2. UAE Breast Cancer Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End-use
  • 9.3.3. South Africa Breast Cancer Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End-use

10. South America Breast Cancer Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Product
  • 10.2.3. By Application
  • 10.2.4. By End-use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Breast Cancer Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End-use
  • 10.3.2. Colombia Breast Cancer Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End-use
  • 10.3.3. Argentina Breast Cancer Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End-use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Breast Cancer Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Baxter Pharmaceuticals India Private Limited.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bristol-Myers Squibb India Private Limited.
• 15.3. Cipla Ltd.
• 15.4. Roche Products (India) Private Limited.
• 15.5. Glenmark Pharmaceuticals Ltd.
• 15.6. Lupin Ltd
• 15.7. Abbott India Laboratories Limited
• 15.8. BIO-RAD LABORATORIES (INDIA) PRIVATE LIMITED.
• 15.9. Siemens Healthcare Private Limited.
• 15.10. Thermo Fisher Scientific India Private Limited.

16. Strategic Recommendations

17. About Us & Disclaimer